Literature DB >> 8531118

Clozapine is oxidized by activated human neutrophils to a reactive nitrenium ion that irreversibly binds to the cells.

Z C Liu1, J P Uetrecht.   

Abstract

Clozapine was oxidized to a reactive intermediate by HOCI, which is the major oxidant produced by activated neutrophils. A mass spectrum was obtained of this reactive intermediate by using a flow system in which the reactants were fed into a mixing chamber and the products flowed directly into a Sciex API III mass spectrometer. The intermediate was observed at m/z 325, which is 2 mass units less than the protonated molecular ion of the parent drug. This intermediate reacted with water to form several products with a m/z at 343. The same products were produced by the oxidation of clozapine by the combination of myeloperoxidase, hydrogen peroxide and chloride ion. The reactive intermediate was trapped by glutathione (GSH) and several conjugates were formed. Nuclear magnetic resonance spectra of the two major conjugates indicated GSH bound to the 6 and 9 positions of the aromatic ring. These data provide further evidence for the formation of a formal nitrenium ion in which the positive charge is highly delocalized. Clozapine was also oxidized by activated neutrophils, and in the presence of GSH, the same GSH conjugates were formed. When therapeutic concentrations of radiolabeled clozapine were used, up to 7% of the drug became irreversibly bound to the neutrophils. Covalent binding was inhibited by about 30% in the presence of 1 mM GSH but was almost abolished at 5 mM GSH. The putative nitrenium ion formed by activated leukocytes could be responsible for clozapine-induced agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531118

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  21 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.

Authors:  K van der Weide; H Loovers; K Pondman; J Bogers; T van der Straaten; E Langemeijer; D Cohen; J Commandeur; J van der Weide
Journal:  Pharmacogenomics J       Date:  2016-05-10       Impact factor: 3.550

3.  Olanzapine and pancytopenia with severe folate deficiency.

Authors:  F Maurier; N Petitpain; J-F Guichard; L Javot; P Tréchot
Journal:  Eur J Clin Pharmacol       Date:  2010-02-06       Impact factor: 2.953

Review 4.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Interactions of recombinant human histamine H₁R, H₂R, H₃R, and H₄R receptors with 34 antidepressants and antipsychotics.

Authors:  Heidrun Appl; Tobias Holzammer; Stefan Dove; Ekkehard Haen; Andrea Strasser; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-28       Impact factor: 3.000

Review 6.  Will routine therapeutic drug monitoring have a place in clozapine therapy?

Authors:  D J Freeman; L K Oyewumi
Journal:  Clin Pharmacokinet       Date:  1997-02       Impact factor: 6.447

Review 7.  More than 25 years of genetic studies of clozapine-induced agranulocytosis.

Authors:  S A J de With; S L Pulit; W G Staal; R S Kahn; R A Ophoff
Journal:  Pharmacogenomics J       Date:  2017-04-18       Impact factor: 3.550

8.  Mechanism of clozapine-induced agranulocytosis : current status of research and implications for drug development.

Authors:  M Pirmohamed; K Park
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

9.  Aminoglutethimide-induced protein free radical formation on myeloperoxidase: a potential mechanism of agranulocytosis.

Authors:  Arno G Siraki; Marcelo G Bonini; JinJie Jiang; Marilyn Ehrenshaft; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2007-06-30       Impact factor: 3.739

10.  Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia.

Authors:  Isabella R Willcocks; Sophie E Legge; Mariana Nalmpanti; Lucy Mazzeo; Adrian King; John Jansen; Marinka Helthuis; Michael J Owen; Michael C O'Donovan; James T R Walters; Antonio F Pardiñas
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.